Article Text

other Versions

PDF
Neurosarcoidosis - a study of 30 new cases
  1. Fady Joseph (fadygjoseph{at}googlemail.com)
  1. University of Bristol Institute of Clinical Neurosciences, Frenchay Hospital, United Kingdom
    1. N J Scolding (n.j.scolding{at}bristol.ac.uk)
    1. University of Bristol Institute of Clinical Neurosciences, United Kingdom

      Abstract

      We studied the frequency, nature, relationship to systemic features, value of investigation findings and outcomes for a cohort of patients with neurosarcoidosis (NS) by performing a retrospective survey of case records from nine District General or Regional Centre hospitals in south-west England and south Wales over a 12-year period (1990-2002). 30 patients (29 Caucasians) were included - 16 (53%) males, 14 (47%) females, including 13 with histological confirmation of CNS disease, making this one of the largest series of biopsy-confirmed NS; the remaining cases had “Probable” NS according to the Zajicek criteria 1. The male preponderance is of interest particularly considering the female predominance of systemic sarcoidosis. The indicative prevalence of NS in this geographical area was estimated at 1 per 100,000. The most frequent features were headaches, visual failure, ataxia and vomiting. Cranial neuropathy occurred in 80% of patients, and as a presenting feature in 50% - though facial nerve involvement was seen in only 23%, and in none of those with definite disease. Unsurprisingly, no diagnostic clinical patterns emerged overall when only definite cases were analysed, but within our Definite group of patients, meningeal and/or parenchymal lesion enhancement was observed in all but one case, while distinction from multiple sclerosis might also be aided by the observation that in all NS CSF samples with positive OCB (27%), banding was accompanied by elevations of CSF protein. From a prognostic perspective, the reported association of seizures in NS with a poor long term outcome was not supported, while the suggestion that myelopathy also predicts an adverse prognosis was confirmed.

      Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.